Mutiple Lenzumestrocel (Neuronata-R® Inj.)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Mutiple Lenzumestrocel (Neuronata-R® Inj.), covering 2025-01-10 to 2025-01-10. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation the Efficacy and Safety of Mutiple Lenzumestrocel (Neuronata-R® Inj.) Treatment in Patients with ALS [Phase 3]